Schloebe A - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis.

Bieber T, Thyssen JP, Irvine AD, Tsunemi Y, Chen YF, Sun L, Schloebe A, Riedl E, Cork MJ. Bieber T, et al. Among authors: schloebe a. Clin Exp Dermatol. 2023 Jul 21;48(8):881-888. doi: 10.1093/ced/llad129. Clin Exp Dermatol. 2023. PMID: 37032446 Free article.

Improvement of head and neck symptoms in patients with atopic dermatitis treated with baricitinib based on five Phase III clinical trials.

Wollenberg A, Lio P, Kleyn E, Bissonnette R, Jose Rueda M, Casillas M, Chen YF, Lu N, Schloebe A, Simpson E. Wollenberg A, et al. Among authors: schloebe a. Eur J Dermatol. 2022 Jul 1;32(4):522-529. doi: 10.1684/ejd.2022.4280. Eur J Dermatol. 2022. PMID: 36301752 Clinical Trial. English.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters